AUSTRALIAN DRUG DEVELOPMENT BLOG
The Latest Blogs from Agilex Biolabs

Author By Agilex Biolabs发布日期
By Dr. Kurt Sales, CSO Summary The following article focuses on the use of flow cytometry in clinical trials and the use of...

Author By Agilex Biolabs发布日期
By William Grenfell, Head of IT In today's digital age, information security is paramount. At Agilex Biolabs, we understand the...

Author By Agilex Biolabs发布日期
By Kim Salvatore, Head of Client and Operational Services The bioanalytical and drug development industry is at the forefront o...

Author By Agilex Biolabs发布日期
There’s a great opportunity for Australian SME’s to take advantage of a well-deserved subsidy! Agilex Biolabs is thrilled t...

Author By Agilex Biolabs发布日期
Research shows that Biotechnology companies have been facing significant challenges – with continual declines in deal making act...

Author By Agilex Biolabs发布日期
By Dr. Kurt Sales, CSO Introduction Immunological assays are essential in drug development, especially for immunomodulatory...

Author By Agilex Biolabs发布日期
By Dr. Kurt Sales, CSO Peripheral Blood Mononuclear Cells (PBMC) are critical for the pharmacodynamic assessment of new drug pr...

Author By Agilex Biolabs发布日期
The Role of Peripheral Blood Mononuclear Cells (PBMCs) in Drug Discovery and Clinical Trials. By Dr. Kurt Sales, CSO In the...

Author By Agilex Biolabs发布日期
By Dr. Kurt Sales, CSO Oligonucleotides, including small interfering RNA (siRNA) and antisense oligonucleotides (ASO), have gai...

Author By Agilex Biolabs发布日期
By Dr. Kurt Sales, CSO In the high-stakes world of drug development, biotech companies face unique challenges at every stage -...

Author By Agilex Biolabs发布日期
By Dr. Kurt Sales, CSO Liquid chromatography-mass spectrometry (LCMS) has become an indispensable tool for the pharmaceutical a...

Author By Agilex Biolabs发布日期
By Dr. Kurt Sales, CSO Preclinical toxicology studies are an essential part of the drug development process as they provide ins...